Note 12 - Segment and Geographic Information

6 Months Ended

Jun. 30, 2014

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

12. Segment and Geographic Information

The Company has one reportable operating segment, the results of which are disclosed in the accompanying unaudited condensed consolidated financial statements.

Product revenue by product group is as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2014		2013		2014		2013
Orthobiologics	$	18,278,254	$	16,506,226	$	29,850,404	$	27,789,773
Dermal		348,961		557,059		537,612		798,643
Surgical		1,376,530		1,830,022		3,128,549		2,818,886
Ophthalmic		363,411		464,340		571,996		1,392,798
Veterinary		900,000		709,760		1,530,000		1,761,796
	$	21,267,156	$	20,067,407	$	35,618,561	$	34,561,896

Total revenue by geographic location and as a percentage of overall total revenue, for the three and six-month periods ended June 30, 2014 and 2013 are as follows (prior period numbers have been reclassified to conform to current period presentation):

	Three Months Ended June 30,
	2014					2013
	Total Revenue		Percentage of Revenue			Total Revenue		Percentage of Revenue
Geographic Location:
United States	$	22,946,738		87	%	$	15,482,068		74	%
Europe		1,793,841		7	%		1,986,195		10	%
Other		1,534,081		6	%		3,360,114		16	%
Total	$	26,274,660		100	%	$	20,828,377		100	%

	Six Months Ended June 30,
	2014					2013
	Total Revenue		Percentage of Revenue			Total Revenue		Percentage of Revenue
Geographic Location:
United States	$	54,480,556		90	%	$	27,765,515		77	%
Europe		3,489,656		6	%		3,569,963		10	%
Other		2,314,735		4	%		4,739,910		13	%
Total	$	60,284,947		100	%	$	36,075,388		100	%